...
首页> 外文期刊>Journal of International Medical Research >MicroRNA-34c-3p target inhibiting NOTCH1 suppresses chemosensitivity and metastasis of non-small cell lung cancer
【24h】

MicroRNA-34c-3p target inhibiting NOTCH1 suppresses chemosensitivity and metastasis of non-small cell lung cancer

机译:MicroRNA-34C-3P靶抑制NOTCH1抑制了非小细胞肺癌的化学敏感性和转移

获取原文
           

摘要

Background Chemotherapy is the standard treatment for non-small cell lung cancer (NSCLC). However, chemoresistance frequently occurs, making the treatment of NSCLC more difficult. Method We combined clinical and experimental studies to establish the role of microRNA (miR)-34c in NSCLC metastasis and chemoresistance. Results MiR-34c expression was significantly decreased in patients with NSCLC who showed a poor chemoresponse and metastasis. Overexpression of miR-34c sensitized NSCLC cells to paclitaxel and cisplatin both in vitro and in vivo . Furthermore, we found that NOTCH1 was target of miR-34c in NSCLC cells and played a key role in the effects of miR-34c on NSCLC. Conclusion NSCLC metastasis and chemoresistance are suppressed though the miR-34c/NOTCH1 axis. MiR-34c has important implications in the development of therapeutic strategies for metastasis and chemoresistance in NSCLC.
机译:背景技术化疗是非小细胞肺癌(NSCLC)的标准处理。然而,经常发生化学性,使NSCLC的处理更加困难。方法组合临床和实验研究,建立MicroRNA(MIR)-34C在NSCLC转移和化学抑制中的作用。结果NSCLC患者显示出差的化学响应和转移的患者MIR-34C表达显着降低。 MiR-34C的过表达在体外和体内敏感的NMSCLC细胞对紫杉醇和顺铂的过度表达。此外,我们发现Notch1是NSCLC细胞中miR-34c的靶标,并在MIR-34c对NSCLC的影响中发挥了关键作用。结论MIR-34C / NOTCH1轴抑制了NSCLC转移和化学抑制。 MIR-34C对NSCLC中的转移和化学性的治疗策略具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号